US Stock
Closed Market
Incyte Stock
•INCYClosed Market
$98,07
-$1,97(1,97%)Past Day
$0(0,00%)After Hours
About Incyte
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. The company is headquartered in Wilmington, Delaware and currently employs 2,844 Read moreSectorHealth Care
IndustryPharmaceuticals, Biotechnology & Life Sciences
ExchangeNASDAQ NMS - GLOBAL MARKET
Employees2,844
HeadquarterWilmington, United States
Websiteincyte.com
SymbolINCY
Key Statistics
General
Valuation Ratios
Profitability
Market Cap0
Dividend Yield$0
Avg. Volume0
Earnings per Share$0
Enterprise Value (EV)$0
52w High$0 (Invalid Date)
52w Low$0 (Invalid Date)
1Y Drawdown0%
EBITDA$0
PEG Ratio0,00
People Also Bought
MRNA$54,10
+8,57%
SAP$199,80
+1,77%
FRSH$8,58
+3,39%
BEN$27,01
+1,92%
ROST$209,85
+6,18%
COUR$6,41
+3,22%
BOX$24,79
+3,64%
LVS$56,88
+2,12%
NTAP$101,19
+2,43%
ICL$5,06
+2,43%
ARE$53,21
+1,90%
BAH$81,33
+2,69%
GRMN$255,95
+2,10%
ACB$3,55
+2,01%
RENT$5,67
+2,35%
MRNA$54,10
+8,57%
SAP$199,80
+1,77%
FRSH$8,58
+3,39%
BEN$27,01
+1,92%
ROST$209,85
+6,18%
COUR$6,41
+3,22%
BOX$24,79
+3,64%
LVS$56,88
+2,12%
NTAP$101,19
+2,43%
ICL$5,06
+2,43%
ARE$53,21
+1,90%
BAH$81,33
+2,69%
GRMN$255,95
+2,10%
ACB$3,55
+2,01%
RENT$5,67
+2,35%
